All Stories

  1. Predictive Modeling of Acute Hypertensive Disorders in a Real-World Cohort: Integrating Clinical Predictors and Data-Driven Methods
  2. Exploring the Impact of Inhaled Corticosteroids on Endothelial Function in Chronic Obstructive Pulmonary Disease Patients Undergoing Pulmonary Rehabilitation
  3. Endotyping Chronic Respiratory Diseases: T2 Inflammation in the United Airways Model
  4. Syncope in the Emergency Department: A Practical Approach
  5. Contemporary Evidence and Practice on Right Heart Catheterization in Patients with Acute or Chronic Heart Failure
  6. Cardiovascular Risk Associated with Alpha-1 Antitrypsin Deficiency (AATD) Genotypes: A Meta-Analysis with Meta-Regressions
  7. The Clinical Application of Established and Emerging Biomarkers for Chronic Respiratory Diseases
  8. Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work
  9. Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients
  10. Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve
  11. Lung Ultrasound in Coronary Care Unit, an Important Diagnostic Tool for Concomitant Pneumonia
  12. From Structural to Functional Hypertension Mediated Target Organ Damage—A Long Way to Heart Failure with Preserved Ejection Fraction
  13. Differences in Diagnosis and Management of Hypertensive Urgencies and Emergencies According to Italian Doctors from Different Departments Who Deal With Acute Increase in Blood Pressure—Data from Gear (Gestione Dell’emergenza e Urgenza in ARea Critica) ...
  14. Arterial Hypertension in Aortic Valve Stenosis: A Critical Update
  15. Reducing Cardiac Injury during ST-Elevation Myocardial Infarction: A Reasoned Approach to a Multitarget Therapeutic Strategy
  16. Association of Myocardial Energetic Efficiency with Circumferential and Longitudinal Left Ventricular Myocardial Function in Subjects with Increased Body Mass Index (the FATCOR Study)
  17. Autocrine Bradykinin Release Promotes Ischemic Preconditioning-Induced Cytoprotection in Bovine Aortic Endothelial Cells
  18. Prognostic impact of increased pulse pressure/stroke index in a registry of hypertensive patients: the Campania Salute Network
  19. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
  20. Cardiac adaptation to hypertension in adult female Dahl salt‐sensitive rats is dependent on ovarian function, but loss of ovarian function does not predict early maladaptation
  21. Higher pulse pressure and risk for cardiovascular events in patients with essential hypertension: The Campania Salute Network
  22. Influence of Left Ventricular Stroke Volume on Incident Heart Failure in a Population With Preserved Ejection Fraction (from the Strong Heart Study)
  23. Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)
  24. Validation of Left Atrial Volume Estimation by Left Atrial Diameter from the Parasternal Long-Axis View
  25. Effect of diabetes and metabolic syndrome on myocardial mechano-energetic efficiency in hypertensive patients. The Campania Salute Network
  26. Obesity and hypertensive heart disease: focus on body composition and sex differences
  27. Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study
  28. Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy
  29. Aortic root dimension and arterial stiffness in arterial hypertension
  30. Type of myocardial infarction presentation in patients with chronic kidney disease
  31. Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: The Strong Heart Study
  32. Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study)
  33. Classes of antihypertensive medications and blood pressure control in relation to metabolic risk factors
  34. Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Kidney Disease